Author:
Santini V.,Alessandrino P.E.,Angelucci E.,Barosi G.,Billio A.,Di Maio M.,Finelli C.,Locatelli F.,Marchetti M.,Morra E.,Musto P.,Visani G.,Tura S.
Subject
Cancer Research,Oncology,Hematology
Reference166 articles.
1. Quality of life assessment in patients affected by myelodysplastic syndrome;Oliva;Blood (ASH Annual Meeting Abstracts),2008
2. The costs of drugs used to treat myelodysplastic syndromes following National Comprehensive Cancer Network Guidelines;Greenberg;J Natl Compr Canc Netw,2008
3. Evidence- and consensus-based guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Haematology;Alessandrino;Haematologica,2002
4. Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Haematology, the Italian Society of Experimental Haematology and the Italian Group for Bone Marrow Transplantation;Barosi;Haematologica,2005
5. A new system for grading recommendations in evidence based guide-lines;Harbour;BMJ,2001
Cited by
102 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献